Table 1.
Baseline parameters of the study population (n: 96).
Parameters | Patient group (n: 48) |
Control group (n:48) |
P |
---|---|---|---|
Age (y) | 39 (20–66) | 41 (22–65) | .592 |
Gender (males, n [%]) | 33 (68.8) | 33 (68.8) | 1.000 |
Heart rate (/min) | 73.5 (50–100) | 70.5 (55–102) | .369 |
WBC count (×106/µL) | 7.6 (4.4–13.1) | 8.1 (3.8–11.1) | .680 |
Hemoglobin (g/dL) | 14.6 (10.2–17.3) | 14.4 (10.5–18.7) | .378 |
Platelet count (×103/µL) | 286 (143–508) | 303 (151–523) | .942 |
Serum creatinine (mg/dL) | 0.84 (0.45–1.25) | 0.80 (0.56–1.10) | .766 |
Alanine aminotransferase (U/L) | 17.6 (10.5–36.0) | 17.4 (10.5–29.6) | .555 |
LDL (mg/dL) | 96 (41–175) | 104 (40–169) | .360 |
HDL (mg/dL) | 44 (30–135) | 50 (24–109) | .459 |
CRP (mg/L) | 5.2 (0.3–74.0) | 1.4 (0.1–11.1) | .007* |
Syndecan (ng/ml) | 6.7 (1.5–35.0) | 5.1 (0.1–12.5) | <.001* |
CIMT (mm) | 0.06 (0.03–0.09) | 0.04 (0.02–0.07) | <.001* |
CIMT = carotid intima-media thickness, CRP = C-reactive protein, HDL = high density lipoprotein, LDL = low density lipoprotein, WBC = white blood cell.
Indicates statistically significant.